Dr. MEHMET UFUK ABACIOGLU

• 1997Istanbul University Istanbul Faculty of Medicine Radiation Oncology
• 1993Istanbul University Istanbul Faculty of Medicine

Experience

• 2024Acıbadem Health Group
• 1998 – 2011Marmara University Faculty of Medicine / Professor of Radiation Oncology / Department of Radiation Oncology
• 2010Neolife Medical Center / Professor of Radiation Oncology
• 1993 – 1997Istanbul Cerrahpaşa Faculty of Medicine / Professor of Radiation Oncology / Department of Radiation Oncology

• Turkish Radiation Oncology Association Board Member-General Secretary 2009-2010, Board Member 2011-2012
• European Organization for Research and Treatment of Cancer (EORTC) Radiation Oncology Group
• Turkish Oncology Group TOG-Central Nervous System Working Group President 2007-2010
• American Society for Radiation Oncology (ASTRO)
• Turkish Lung Cancer Association (TAKD)
• American Society of Clinical Oncology (ASCO)
• Member of the Executive Board of the European Association of Neurooncology (EANO) 2010-2014
• Neuro-Oncology Association Board Member – Vice President 2013-2015, President 2015
• Rare Cancer Network
• European Society for Therapeutic Radiology and Oncology (ESTRO)
• Honorary membership of Romanian Urology Association (June 2015)

• Heidelberg University Hospital, about the Phase-ll Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Primary Glioblastoma (CLEOPATRA)Eur Assoc Neurooncol Mag, 4(1): 47-48, (2014) Abacioglu U. Interview with Dr Stephanie E Combs
• V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neckRadiai Oncol, 2014; 9:104 Akgun Z, Atasoy BM, Ozen Z, Yavuz D, Gulluoglu B, Sengoz M, Abacioglu U
• Critical appraisal of RapidArc radiosurgery with flattening filter free photon beams for benign brain lesions in comparison to GammaKnife: a treatment planning studyRadiai Oncol, 2014; 9:119. Abacioglu U, Ozen Z, Yilmaz M, Arifoglu A, Gunhan B, Kayalilar N, Peker S, Sengoz M, Gurdalli S, Cozzi L
• MSKCC, about the RTOG 1114-Phase II randomized Study of Chemotherapy with and without Low-Dose WBRT for Primary Central Nervous LymphomaEur Assoc Neurooncol Mag, 4(3): 130-131, (2014). Abacioglu U. Interview with Dr. Antonio Omuro
• MD, VU University Medical Center, Amsterdam, about the Randomised Trial on Internet-Based Treatment of Depressive Symptoms in Glioma PatientsEur Assoc Neurooncol Mag, 4(2): 90-91, (2014) Abacioglu U. Interview with Florien Boele, MSc, and Martin Klein
• Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patientsClin Transl Oncol, 16(1): 91-5, (2014) Atasoy BM, Dane F, Alsari Cetin I, Ozgen Z, Ucuncu Kefeli A, Ibrahimov R, Turhal NS, Abacioglu U, Turkeri L
• Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients?J BUON. 2013;18(2):453-8 Alsan Cetin I, Akgun Z, Atasoy BM, Fulden Yumuk P, Abacioglu U
• The benefit of whole brain reirradiation in patients with multiple brain métastasésRadiai Oncol, 2013; 8(1): 186 Ozgen Z, Atasoy BM, Ucuncu Kefeli A, Seker A, Dane F, Abacioglu U
• The effect of magnesium and vitamin E pre-treatments on irradiation-induced oxidative injury of cardiac and pulmonary tissues in rats: a randomized experimental studyAnadolu Kardiyol Derg, 12(6), SOS-14, (2012) 40. Atasoy BM, Ozgen Z, Bostanci K, Yiiksel M, Ozen Z, Ibrahimov R, Abacioglu U.
• Flealth-Related Quality of Life During Postoperative Chemoradiotherapy with Oral Uracil-Tegafur and Leucovorin in Rectal Cancer PatientsHepatogastroenterology. Nov 16;60(123). (2012 42. Ozgen Z, Ozden S, Dane F, Atasoy BM, Akgun Z, Yumuk PF, Mayadagli A, Turhal NS, Abacioglu U